Skip to main content

Search

24 result(s) for 'author#Cornelis JH van de Velde' within BMC

Page 1 of 2

Sort by: Relevance | Date

  1. The presence of lymph node metastases remains the most reliable prognostic predictor and the gold indicator for adjuvant treatment in colon cancer (CC). In spite of a potentially curative resection, 20 to 30% ...

    Authors: Daniel J Lips, Boukje Koebrugge, Gerrit Jan Liefers, Johannes C van de Linden, Vincent THBM Smit, Hans FM Pruijt, Hein Putter, Cornelis JH van de Velde and Koop Bosscha
    Citation: BMC Surgery 2011 11:11
  2. Invasion and metastasis is a complex process governed by the interaction of genetically altered tumor cells and the immunological and inflammatory host reponse. Specific T-cells directed against tumor cells an...

    Authors: Iris D Nagtegaal, Corrie AM Marijnen, Elma Klein Kranenbarg, Adri Mulder-Stapel, Jo Hermans, Cornelis JH van de Velde and J Han JM van Krieken
    Citation: BMC Cancer 2001 1:7
  3. Breast cancer at a young age is associated with an unfavorable prognosis. Very young patients with breast cancer therefore are advised to undergo adjuvant chemotherapy irrespective of tumor stage or grade. How...

    Authors: Jos A van der Hage, J Sven D Mieog, Marc J van de Vijver and Cornelis JH van de Velde
    Citation: Breast Cancer Research 2007 9:R70
  4. Radical surgery is the cornerstone in the treatment of resectable gastric cancer. The Intergroup 0116 and MAGIC trials have shown benefit of postoperative chemoradiation and perioperative chemotherapy, respect...

    Authors: Johan L Dikken, Johanna W van Sandick, HA Maurits Swellengrebel, Pehr A Lind, Hein Putter, Edwin PM Jansen, Henk Boot, Nicole CT van Grieken, Cornelis JH van de Velde, Marcel Verheij and Annemieke Cats
    Citation: BMC Cancer 2011 11:329
  5. Young age at the time of diagnosis of breast cancer is an independent factor of poor prognosis. In many treatment guidelines, the recommendation is to treat young patients with adjuvant chemotherapy regardless...

    Authors: Jos A van der Hage, J Sven D Mieog, Cornelis JH van de Velde, Hein Putter, Harry Bartelink and Marc J van de Vijver
    Citation: Breast Cancer Research 2011 13:R68
  6. The molecular determinants of carcinogenesis, tumor progression and patient prognosis can be deduced from simultaneous comparison of thousands of genes by microarray analysis. However, the presence of stroma c...

    Authors: Elza C de Bruin, Simone van de Pas, Esther H Lips, Ronald van Eijk, Minke MC van der Zee, Marcel Lombaerts, Tom van Wezel, Corrie AM Marijnen, J Han JM van Krieken, Jan Paul Medema, Cornelis JH van de Velde, Paul HC Eilers and Lucy TC Peltenburg
    Citation: BMC Genomics 2005 6:142
  7. Previous studies indicate that alterations in Human Leukocyte Antigen (HLA) class I expression are frequent in colorectal tumors. This would suggest serious limitations for immunotherapy-based strategies invol...

    Authors: Jan Willem F Dierssen, Noel FCC de Miranda, Arend Mulder, Marjo van Puijenbroek, Willem Verduyn, Frans HJ Claas, Cornelis JH van de Velde, Gert Jan Fleuren, Cees J Cornelisse, Willem E Corver and Hans Morreau
    Citation: BMC Cancer 2006 6:233
  8. Infection with H. pylori is important in the etiology of gastric cancer. Gastric cancer is infrequent in Africa, despite high frequencies of H. pylori infection, referred to as the African enigma. Variation in en...

    Authors: Tineke E Buffart, Melanie Louw, Nicole CT van Grieken, Marianne Tijssen, Beatriz Carvalho, Bauke Ylstra, Heike Grabsch, Chris JJ Mulder, Cornelis JH van de Velde, Schalk W van der Merwe and Gerrit A Meijer
    Citation: BMC Medical Genomics 2011 4:7
  9. Post-translational modification of histone tails by methylation plays an important role in tumorigenesis. In this study, we investigated the nuclear expression of H3K4me3, H3K9me3 and H4K20me3 in early-stage c...

    Authors: Anne Benard, Inès J Goossens-Beumer, Anneke Q van Hoesel, Wouter de Graaf, Hamed Horati, Hein Putter, Eliane CM Zeestraten, Cornelis JH van de Velde and Peter JK Kuppen
    Citation: BMC Cancer 2014 14:531
  10. Whereas ultra-short stay (day care or 24 hour hospitalisation) following breast cancer surgery was introduced in the US and Canada in the 1990s, it is not yet common practice in Europe. This paper describes th...

    Authors: Mascha de Kok, Caroline NA Frotscher, Trudy van der Weijden, Alfons GH Kessels, Carmen D Dirksen, Cornelis JH van de Velde, Jan A Roukema, Antoine VRJ Bell, Fred W van der Ent and Maarten F von Meyenfeldt
    Citation: BMC Cancer 2007 7:117
  11. Chromosomal instability (CIN) is the most prevalent type of genomic instability in gastric tumours, but its role in malignant transformation of the gastric mucosa is still obscure. In the present study, we set...

    Authors: Tineke E Buffart, Beatriz Carvalho, Thomas Mons, Rui M Reis, Cátia Moutinho, Paula Silva, Nicole CT van Grieken, Michael Vieth, Manfred Stolte, Cornelis JH van de Velde, Evelin Schrock, Anja Matthaei, Bauke Ylstra, Fátima Carneiro and Gerrit A Meijer
    Citation: BMC Genomics 2007 8:345
  12. Cell surface NKG2D ligands (NKG2DL) bind to the activating NKG2D receptor present on NK cells and subsets of T cells, thus playing a role in initiating an immune response. We examined tumor expression and prog...

    Authors: Esther M de Kruijf, Anita Sajet, Johanna GH van Nes, Hein Putter, Vincent THBM Smit, Robert A Eagle, Insiya Jafferji, John Trowsdale, Gerrit Jan Liefers, Cornelis JH van de Velde and Peter JK Kuppen
    Citation: BMC Cancer 2012 12:24
  13. The receptor for urokinase-type plasminogen activator (uPAR) is associated with cancer development and progression. Within the tumor microenvironment uPAR is expressed by malignant cells as well as tumor-assoc...

    Authors: Martin C Boonstra, Floris PR Verbeek, Andrew P Mazar, Hendrica AJM Prevoo, Peter JK Kuppen, Cornelis JH van de Velde, Alexander L Vahrmeijer and Cornelis FM Sier
    Citation: BMC Cancer 2014 14:269
  14. Breast cancer is a heterogeneous disease with a highly variable clinical outcome in which both genetic and epigenetic changes have critical roles. We investigated tumor expression levels of histone-modifying e...

    Authors: Remco S Derr, Anneke Q van Hoesel, Anne Benard, Inès J Goossens-Beumer, Anita Sajet, N Geeske Dekker-Ensink, Esther M de Kruijf, Esther Bastiaannet, Vincent THBM Smit, Cornelis JH van de Velde and Peter JK Kuppen
    Citation: BMC Cancer 2014 14:604